Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin...
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Inactivation of CDH1, encoding E-cadherin, promotes cancer initiation and progression. According to a newly proposed molecular mechanism, loss of E-cadherin triggers an upregulation of the anti-apoptotic oncoprotein BCL2. Conversely, reconstitution of E-cadherin counteracts overexpression of BCL2. This reciprocal regulation is thought to be critica...
Alternative Titles
Full title
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1428933974
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1428933974
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0073062